Navigation Links
Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Jun 4, 2007 - Acorda Therapeutics, Inc.(R) (Nasdaq: ACOR) today announced that the Company presented a "meta-analysis" or combined analysis of two clinical trials of Fampridine-SR in multiple sclerosis during a poster session at the Americas Committee for Treatment and Research in MS (ACTRIMS) Meeting in Washington, D.C. on Saturday, June 2, 2007. The poster, "Validation of Consistent Improvement in Walking Speed on the Timed 25 Foot Walk as a Measure of Clinically Meaningful Change," was presented by Andrew Goodman, M.D., Director of the Multiple Sclerosis Center at the University of Rochester.

The objective of the analysis was to validate a consistent response criterion as a measure of clinically meaningful change. A consistent timed walk responder was defined as a subject whose walking speeds for at least three of the four on-treatment visits were faster than the fastest speed across any of their five non-treatment visits. In both studies, Fampridine-SR treatment was associated with significantly increased probability of this response compared to placebo (p less than 0.001). Both clinical trials were double-blind, placebo-controlled, parallel group, multi-center studies. The analysis was designed after the data from the first study were available. A total of 501 patients were included in the analysis.

The clinical meaningfulness of this response criterion was assessed primarily by use of the 12-Item MS Walking Scale (MSWS-12), a questionnaire in which the patient rates the clinical impact of his or her walking disability on activities of daily life. Additional criteria for clinical meaningfulness included a seven-point Subject Global Impression (SGI) and a seven-point Clinician Global Impression (CGI). In the meta-analysis, timed-walk responders had significantly greater average improvements from baseline in the MSWS-12 score than the non-responders in both studies in
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
2. Acorda Therapeutics to Host Analyst and Investor Reception
3. Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data Selected for Scientific Highlights Program at the American Academy of Neurology Meeting
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Acorda Therapeutics Presents Fampridine Data ACTRIMS Meeting
(Date:4/20/2015)... , April 20, 2015  Sigma-Aldrich Corporation ... Corporate Responsibility (CR) Magazine,s list of the 100 ... on outstanding corporate responsibility performance.  Sigma-Aldrich ranked fifth, ... appearance on the list. "We are ... corporate responsibility efforts and we are extremely pleased ...
(Date:4/20/2015)... The preclinical contract research organization Absorption Systems ... safety testing of medical devices, announces that its Chief Scientist, ... " Drug Transporters in ADME: From the Bench to the ... title of Dr. Hidalgo,s talk is "Modern Tools for the ... Tools of the Future." The workshop, organized jointly ...
(Date:4/20/2015)...  Ameritox,s Ingenuity Health, a leading provider of monitoring ... at the National Council of Behavioral Health annual conference ... nearly 25 percent of the samples collected from patients ... prescribed antipsychotic medication. ... Medication nonadherence ...
Breaking Medicine Technology:Sigma-Aldrich Named to CR Magazine's 100 Best Corporate Citizens List 2Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3
... FOREST, Ill., April 11, 2011 PharMEDium Healthcare Corporation ... of Anesthesiologists (ASA), as a part of a new ... practice management companies. David N. Jonas, PharMEDium ... ASA,s efforts to advance the anesthesiology field through leadership, ...
... In response to Thursday,s Medicare Payment Advisory ... substantially higher levels of advanced diagnostic imaging services ... approval before being able to provide those services, ... instead look to existing clinical decision support tools ...
Cached Medicine Technology:PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA) 2Healthcare Providers, Technology Experts Call for Use of Existing Decision Support Tools to Promote Diagnostic Imaging Appropriate Use 2Healthcare Providers, Technology Experts Call for Use of Existing Decision Support Tools to Promote Diagnostic Imaging Appropriate Use 3
(Date:4/21/2015)... 2015 The Northeast Football Clinic (NEFC) ... Academy prep school in Byfield, MA. Applications are being ... boys entering grades 6-12. , The outstanding professional, college, ... fall coaching. , Offensive and defensive linemen ... these the most unsung positions on the field, the ...
(Date:4/21/2015)... Dr. Zain Kadri, a Beverly Hills plastic ... takes a close look at the rise of plastic surgery ... on both Dr. Kadri’s website and RedOrbit , is ... Age of the Selfie.” According to Dr. Kadri, who offers ... variety of A-list patients, the trend of taking selfies has ...
(Date:4/21/2015)... Sunnyvale, CA (PRWEB) April 21, 2015 ... research solutions for biopharmaceutical development, today announced that the ... at the University of Ottawa has acquired a Freeslate ... and Screening Pressure Reactor (SPR) to accelerate ... the High-Throughput Experimentation Facility where they will be available ...
(Date:4/21/2015)... Spring and summer are popular seasons to ... for the holidays or simply taking vacations. Deciding what ... can be a difficult choice. Pet-friendly accommodations are gaining ... becoming a more common option. Royal Flush Havanese ... pet-friendly accommodations a positive experience. , 1.) Firstly, it ...
(Date:4/21/2015)... This program provides physical therapists, ... occupational therapist assistants, teachers, and other school based ... children across the autism spectrum succeed in the ... Inc. , Used throughout the United ... yoga curriculum addresses learning and behavior issues across ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:Beverly Hills Plastic Surgery Expert Dr. Zain Kadri Releases Thought-Provoking New Infographic 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 2Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 3Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 4Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2
... To Stay Happy and Healthy This WinterSAN JOSE, Calif., ... avoiding the "winter blues" is to set small goals, ... and exercising, for a well-rounded approach to life. This ... Day of the Year," January 26, 2009, designated by ...
... Strong Health and Economic Benefits of OTC Heartburn ... Consumer Healthcare Products Association (CHPA) and The Nielsen ... over-the-counter (OTC) heartburn medications and estimates that OTC ... each in office visits and medication costs annually. ...
... and print media; Mike Ditka, Frank Gifford, Michael Irvin, Tony Dorsett, ... Dickerson, Deacon Jones, Andre Reed, Tony Dorsett, Mercury Morris and many ... ... January 26, 2009 -- The Gridiron Greats Assistance Fund ...
... Inc. announces leading stem cell specialist Dr Nabil Dib, MD as ... President of the International Society for Cardiovascular Translational Research (ISCTR) and ... ... San Diego, CA (PRWEB) January 26, 2009 -- Stemedica Cell ...
... DNA solves another mystery when 57 year old Fred George discovered he ... fun and sometimes more seriously - accused his wife of having had ... rest of the family. , ... Pembroke, MA (PRWEB) January 26, 2009 ...
... injuries accounted for just 8 percent of all ... were relatively common in predominately male sports such ... (18 percent) and football (12 percent). Moreover, boys ... in soccer and baseball/softball. , ...
Cached Medicine News:Health News:Natural Solutions for the Most Depressing Day of the Year 2Health News:Natural Solutions for the Most Depressing Day of the Year 3Health News:Natural Solutions for the Most Depressing Day of the Year 4Health News:Natural Solutions for the Most Depressing Day of the Year 5Health News:CHPA, Nielsen: OTC Heartburn Therapy Saves Nearly $800 Million Annually, Vast Majority of OTC Heartburn Consumers Satisfied 2Health News:CHPA, Nielsen: OTC Heartburn Therapy Saves Nearly $800 Million Annually, Vast Majority of OTC Heartburn Consumers Satisfied 3Health News:100 NFL Legends Coming Together in Tampa During Super Bowl Week to Raise Awareness and Funds for Retired Players in Crisis 2Health News:100 NFL Legends Coming Together in Tampa During Super Bowl Week to Raise Awareness and Funds for Retired Players in Crisis 3Health News:100 NFL Legends Coming Together in Tampa During Super Bowl Week to Raise Awareness and Funds for Retired Players in Crisis 4Health News:Dr Nabil Dib Takes on Special Advisor Role to the Stemedica Board of Directors 2Health News:DNA Solves Switched at Birth Mystery ... After 57 Years 2Health News:DNA Solves Switched at Birth Mystery ... After 57 Years 3Health News:Shoulder injuries in US high school athletes occur more often in boys 2
... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek® ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
... Endoscopic CycloPhotocoagulation (ECP) is a surgical ... endoscopy and visualized laser application. The ciliary ... by the surgeon, from the anterior or ... time. The target tissues are easily and ...
... a surgical approach to glaucoma management that ... The ciliary body (which produces aqueous humour) ... anterior or posterior segment, through the endoscope ... easily and accurately identified utilizing endoscopy. This ...
... (ECP) is a surgical approach to glaucoma ... laser application. The ciliary body (which produces ... from the anterior or posterior segment, through ... tissues are easily and accurately identified utilizing ...
Medicine Products: